Literature DB >> 12887026

Seroprevalence of Trypanosoma cruzi infection among school-age children in the endemic area of Guatemala.

Nidia R Rizzo1, Byron A Arana, Anaite Diaz, Celia Cordon-Rosales, Robert E Klein, Malcolm R Powell.   

Abstract

In support of the National Program for Chagas Disease Control, we conducted a cross-sectional study to estimate the seroprevalence rate of Trypanosoma cruzi infection across the five Departments (Chiquimula, Jalapa, Zacapa, Jutiapa, and Santa Rosa) that are believed to comprise the entire principal endemic area in Guatemala. Also, so that the results could be used to identify areas of active transmission, we conducted the survey in school-aged children. We used an experimental enzyme-linked immunosorbent assay with blood samples obtained by finger prick to estimate the seroprevalence of T. cruzi. This assay has been previously tested and showed good sensitivity and specificity. Overall, the seropositivity rate for T. cruzi infection was 5.28% (235 of 4,450). Of 173 communities evaluated, 35 (20.23%) had a seropositive rate ranging from 10% to 45%. A number of parameters, including but not limited to living conditions, were examined for possible association with seropositivity. While there are several associations, the strongest association with seropositivity is living in a house with a thatch roof. The survey results will permit the Ministry of Health to stratify T. cruzi-endemic communities, enabling local health authorities to efficiently focus on vector control operations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887026

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  6 in total

1.  Triatomine infestation in Guatemala: spatial assessment after two rounds of vector control.

Authors:  Jennifer Manne; Jun Nakagawa; Yoichi Yamagata; Alexander Goehler; John S Brownstein; Marcia C Castro
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

2.  Dealing with initial inconclusive serological results for chronic Chagas disease in clinical practice.

Authors:  J S Lapa; R M Saraiva; A M Hasslocher-Moreno; I Georg; A S Souza; S S Xavier; P E A A do Brasil
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-08       Impact factor: 3.267

3.  Autonomic dysfunction and risk factors associated with Trypanosoma cruzi infection among children in Arequipa, Peru.

Authors:  Natalie M Bowman; Vivian Kawai; Robert H Gilman; Cesar Bocangel; Gerson Galdos-Cardenas; Lilia Cabrera; Michael Z Levy; Juan Geny Cornejo del Carpio; Freddy Delgado; Lauren Rosenthal; Vivian V Pinedo-Cancino; Francis Steurer; Amy E Seitz; James H Maguire; Caryn Bern
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

4.  A decade of vector control activities: Progress and limitations of Chagas disease prevention in a region of Guatemala with persistent Triatoma dimidiata infestation.

Authors:  Jose G Juarez; Pamela M Pennington; Joe P Bryan; Robert E Klein; Charles B Beard; Elsa Berganza; Nidia Rizzo; Celia Cordon-Rosales
Journal:  PLoS Negl Trop Dis       Date:  2018-11-06

5.  Towards Chagas disease elimination: Neonatal screening for congenital transmission in rural communities.

Authors:  Pamela Marie Pennington; José Guillermo Juárez; Margarita Rivera Arrivillaga; Sandra María De Urioste-Stone; Katherine Doktor; Joe P Bryan; Clara Yaseli Escobar; Celia Cordón-Rosales
Journal:  PLoS Negl Trop Dis       Date:  2017-09-11

6.  Implementation science: Epidemiology and feeding profiles of the Chagas vector Triatoma dimidiata prior to Ecohealth intervention for three locations in Central America.

Authors:  Raquel Asunción Lima-Cordón; Lori Stevens; Elizabeth Solórzano Ortíz; Gabriela Anaité Rodas; Salvador Castellanos; Antonieta Rodas; Vianney Abrego; Concepción Zúniga Valeriano; María Carlota Monroy
Journal:  PLoS Negl Trop Dis       Date:  2018-11-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.